Home » US COURT FAVOURS RANBAXY IN LIPITOR PATENT CASE
US COURT FAVOURS RANBAXY IN LIPITOR PATENT CASE
Country's biggest drug maker, Ranbaxy Laboratories Ltd on Thursday said a US Appeals Court has ruled in its favour in the patent infringement case with Pfizer for cholesterol-lowering drug Atorvastatin (Lipitor).
The Economic Times (http://economictimes.indiatimes.com/articleshow/1844892.cms)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May